These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10917618)

  • 1. Gene structure of apolipoprotein(a) and the regulation of its expression.
    Knight BL
    Biochem Soc Trans; 1999 Aug; 27(4):447-52. PubMed ID: 10917618
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic polymorphisms of the gene for apolipoprotein(a) and their association with lipoprotein(a) levels and myocardial infarction.
    Thillet J
    Biochem Soc Trans; 1999 Aug; 27(4):463-6. PubMed ID: 10917621
    [No Abstract]   [Full Text] [Related]  

  • 3. Transgenic rabbits expressing human apolipoprotein(a) as a useful model for the study of lipoprotein(a).
    Fan J; Challah M; Shimoyamada H; Watanabe T
    Ann N Y Acad Sci; 2000 May; 902():347-51. PubMed ID: 10865861
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipoprotein(a): biochemistry and genetics.
    Hegele RA
    Can J Cardiol; 1992 Nov; 8(9):893-5. PubMed ID: 1486540
    [No Abstract]   [Full Text] [Related]  

  • 5. Transgenic rabbits expressing human apolipoprotein (a).
    Fan J; Watanabe T
    J Atheroscler Thromb; 2000; 7(1):8-13. PubMed ID: 11425047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial hardening in mice.
    Scott J
    Nature; 1992 Dec; 360(6405):631-2. PubMed ID: 1465121
    [No Abstract]   [Full Text] [Related]  

  • 7. Pentanucleotide TTTTA and G/A -914 DNA polymorphisms in apolipoprotein(a) promoter: genotyping by single-tube PCR.
    Zivković M; Stanković A; Alavantić D
    Clin Chem Lab Med; 2003 May; 41(5):632-3. PubMed ID: 12812259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.
    Belczewski AR; Ho J; Taylor FB; Boffa MB; Jia Z; Koschinsky ML
    Biochemistry; 2005 Jan; 44(2):555-64. PubMed ID: 15641780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of human apolipoprotein [a] secretion from mouse hepatocyte cultures.
    Wang J; Boedeker J; Hobbs HH; White AL
    J Lipid Res; 2001 Jan; 42(1):60-9. PubMed ID: 11160366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apo(a) expression in transgenic mice.
    Hobbs HH; Chiesa G; Gaw A; Lawn R; Maika SD; Koschinsky M; Hammer R
    Ann N Y Acad Sci; 1994 Apr; 714():231-6. PubMed ID: 8017772
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular basis of the interaction between LDL and recombinant apo(a).
    Helmhold M; Ernst A; Brunner C; Breuer U; Armstrong VW; Müller HJ
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():36-8. PubMed ID: 8767455
    [No Abstract]   [Full Text] [Related]  

  • 12. Apolipoprotein(a) gene enhancer resides within a LINE element.
    Yang Z; Boffelli D; Boonmark N; Schwartz K; Lawn R
    J Biol Chem; 1998 Jan; 273(2):891-7. PubMed ID: 9422746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperlipoprotein (a)-emia determined by genetic polymorphisms in apolipoprotein (a) gene].
    Ichinose A
    Brain Nerve; 2008 Nov; 60(11):1307-17. PubMed ID: 19069164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus.
    Peros E; Geroldi D; Bugatti S; Caporali R; Rossi P; Montecucco C; D'Angelo A; Emanuele E
    Int J Mol Med; 2005 Apr; 15(4):661-5. PubMed ID: 15754029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a), apolipoprotein(a) phenotypes, and nephropathy in NIDDM patients.
    Akita H; Chiba H; Noritake M; Katsura Y; Udo Y; Shibuya H; Hui SP; Takahashi Y; Nagasaka H
    Diabetes Care; 1996 Sep; 19(9):1036-7. PubMed ID: 8875111
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible association between genetic variability at the apolipoprotein(a) locus and Alzheimer's disease in apolipoprotein E2 carriers.
    Compton D; Wavrant DeVriéze F; Petersen RC; Tangalos E; Li L; Hardy J
    Neurosci Lett; 2002 Oct; 331(1):60-2. PubMed ID: 12359323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction.
    Holmer SR; Hengstenberg C; Kraft HG; Mayer B; Pöll M; Kürzinger S; Fischer M; Löwel H; Klein G; Riegger GA; Schunkert H
    Circulation; 2003 Feb; 107(5):696-701. PubMed ID: 12578871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of polymorphisms in the 5'-flanking region of the gene for apolipoprotein(a).
    Ichinose A; Kuriyama M
    Biochem Biophys Res Commun; 1995 Apr; 209(1):372-8. PubMed ID: 7726859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic aspects of high variability of lipoprotein(a) levels].
    Zídková K; Zlatohlávek L; Ceska R
    Cas Lek Cesk; 2007; 146(8):653-7. PubMed ID: 17874731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of N-linked glycans, chaperone interactions and proteasomes in the intracellular targeting of apolipoprotein(a).
    Wang J; White AL
    Biochem Soc Trans; 1999 Aug; 27(4):453-8. PubMed ID: 10917619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.